Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Per Olsson, Javier Sanchez, Tom Eirik Mollnes & Johan Riesenfeld. (2000) On the blood compatibility of end-point immobilized heparin . Journal of Biomaterials Science, Polymer Edition 11:11, pages 1261-1273.
Read now
Read now
Tor Ole Klemsdal. (1997) Transdermal Kinetics and Nitrate Tolerance. Measurements of Vasodilation by Photoplethysmography. Scandinavian Cardiovascular Journal 31:6, pages 369-369.
Read now
Read now
Lars Bagge, Jan W. Borowiec, Stefan Thelin & Jan Hultman. (1997) Haemostasis at Low Heparin Dosage During Cardiopulmonary Bypass with Heparin-coated Circuits in Pigs. Scandinavian Cardiovascular Journal 31:5, pages 275-281.
Read now
Read now
Jan W. Borowiec, Leif Hagman, Thomas H. Tötterman, Marcela Pekna, Per Venge & Stefan Thelin. (1995) Circulating Cytokines and Granulocyte-Derived Enzymes During Complex Heart Surgery: A Clinical Study with Special Reference to Heparin-Coating of Cardiopulmonary Bypass Circuits. Scandinavian Journal of Thoracic and Cardiovascular Surgery 29:4, pages 167-174.
Read now
Read now
Mats Ernofsson, Stefan Thelin & Agneta Siegbahn. (1995) Thrombin Generation During Cardiopulmonary Bypass Using Heparin-Coated or Standard Circuits. Scandinavian Journal of Thoracic and Cardiovascular Surgery 29:4, pages 157-165.
Read now
Read now
Marcela Pekna, Jan Borowiec, Magne K. Fagerhol, Per Venge & Stefan Thelin. (1994) Biocompatibility of Heparin-Coated Circuits Used in Cardiopulmonary Bypass. Scandinavian Journal of Thoracic and Cardiovascular Surgery 28:1, pages 5-11.
Read now
Read now
Articles from other publishers (51)
Kalervo Werkkala, Janne J. Jokinen, Leena Soininen, Göran Dellgren, Stefan Hallhagen, Fredrik Sundberg, Jonas Andersson, Lars I. Dahms, Nadine Jurrmann & Simon Ersel. (2016) Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps. ASAIO Journal 62:2, pages 139-142.
Crossref
Crossref
Paul C. Begovac, Daniel Pond, Jennifer Recknor & Elisabeth Scholander. 2015. Drug-Device Combinations For Chronic Diseases. Drug-Device Combinations For Chronic Diseases
142
181
.
J. Nilsson, S. Scicluna, G. Malmkvist, L. Pierre, L. Algotsson, P. Paulsson, H. Bjursten & P. Johnsson. (2012) A randomized study of coronary artery bypass surgery performed with the Resting Heart System utilizing a low vs a standard dosage of heparin. Interactive CardioVascular and Thoracic Surgery 15:5, pages 834-839.
Crossref
Crossref
M. Ranucci. 2012. Minimized Cardiopulmonary Bypass Techniques and Technologies. Minimized Cardiopulmonary Bypass Techniques and Technologies
17
34
.
Marco Ranucci, Solomon Aronson, Wulf Dietrich, Cornelius M. Dyke, Axel Hofmann, Keyvan Karkouti, Marcel Levi, Gavin J. Murphy, Frank W. Sellke, Linda Shore-Lesserson & Christian von Heymann. (2011) Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice?. The Journal of Thoracic and Cardiovascular Surgery 142:2, pages 249.e1-249.e32.
Crossref
Crossref
Victor A. Ferraris, Jeremiah R. Brown, George J. Despotis, John W. Hammon, T. Brett Reece, Sibu P. Saha, Howard K. Song, Ellen R. Clough, Linda J. Shore-Lesserson, Lawrence T. Goodnough, C. David Mazer, Aryeh Shander, Mark Stafford-Smith, Jonathan Waters, Robert A. Baker, Timothy A. Dickinson, Daniel J. FitzGerald, Donald S. Likosky & Kenneth G. Shann. (2011) 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. The Annals of Thoracic Surgery 91:3, pages 944-982.
Crossref
Crossref
Marco Ranucci, Anna Balduini, Antonio Ditta, Alessandra Boncilli & Simonetta Brozzi. (2009) A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome. The Annals of Thoracic Surgery 87:4, pages 1311-1319.
Crossref
Crossref
Theodore E. Warkentin & Andreas GreinacherDavid H. Lee & Theodore E. Warkentin. 2007. Heparin-Induced Thrombocytopenia. Heparin-Induced Thrombocytopenia
67
116
.
Ravi Taneja & Davy CH Cheng. (2006) Con: Heparin-Bonded Cardiopulmonary Bypass Circuits Should Be Routine for All Cardiac Surgical Procedures. Anesthesia & Analgesia 103:6, pages 1370-1372.
Crossref
Crossref
Gregory A. Nuttall, William C. Oliver, David N. Fass, Whyte G. Owen, Devin Dinenno, Mark H. Ereth, Brent A. Williams, Joseph A. Dearani & Hartzell V. Schaff. (2006) A Prospective, Randomized Platelet-Function Study of Heparinized Oxygenators and Cardiotomy Suction. Journal of Cardiothoracic and Vascular Anesthesia 20:4, pages 554-561.
Crossref
Crossref
Keisuke Ichinose, Taisuke Okamoto, Hironari Tanimoto, Atsushi Yoshitake, Masafumi Tashiro, Yuji Sakanashi, Katsuyuki Kuwana, Koichiro Tahara, Masahiro Kamiya & Hidenori Terasaki. (2004) Comparison of a New Heparin-coated Dense Membrane Lung with Nonheparin-coated Dense Membrane Lung for Prolonged Extracorporeal Lung Assist in Goats. Artificial Organs 28:11, pages 993-1001.
Crossref
Crossref
Laurance Lequier. (2016) Extracorporeal Life Support in Pediatric and Neonatal Critical Care: A Review. Journal of Intensive Care Medicine 19:5, pages 243-258.
Crossref
Crossref
Patrícia da Luz Moreira, Paula Rulf Marreco, Angela Maria Moraes, Maria Lúcia Furlan Wada & Selma Candelária Genari. (2003) Analysis of cellular morphology, adhesion, and proliferation on uncoated and differently coated PVC tubes used in extracorporeal circulation (ECC). Journal of Biomedical Materials Research Part B: Applied Biomaterials 69B:1, pages 38-45.
Crossref
Crossref
William C. OliverJrJr. (2016) Overview of Heparin and Protamine Management and Dosing Regimens in Pediatric Cardiac Surgical Patients. Seminars in Cardiothoracic and Vascular Anesthesia 7:4, pages 387-410.
Crossref
Crossref
Rena M. Cornelius, Javier Sanchez, Per Olsson & John L. Brash. (2003) Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin. Journal of Biomedical Materials Research 67A:2, pages 475-483.
Crossref
Crossref
Gabriel S. Aldea, Louise O. Soltow, Wayne L. Chandler, Christopher M. Triggs, Craig R. Vocelka, Gregory I. Crockett, Yong T. Shin, William E. Curtis & Edward D. Verrier. (2002) Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. The Journal of Thoracic and Cardiovascular Surgery 123:4, pages 742-755.
Crossref
Crossref
Javier Sánchez, Per Birger Lundquist, Graciela Elgue, Rolf Larsson & Per Olsson. (2002) Measuring the degree of plasma contact activation induced by artificial materials. Thrombosis Research 105:5, pages 407-412.
Crossref
Crossref
M.E. Mukadam, P. Pritchard, D. Riddington, M. Wilkes, T.R. Graham, Jay Charles Horrow & Bruce D. Spiess. (2001) Case 7—2001 Management during cardiopulmonary bypass of patients with presumed fish allergy. Journal of Cardiothoracic and Vascular Anesthesia 15:4, pages 512-519.
Crossref
Crossref
Staffan Svenmarker, Erik Sandström, Thomas Karlsson, Sören Häggmark, Erica Jansson, Micael Appelblad, Ronny Lindholm & Torkel Åberg. (2001) Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits. European Journal of Cardio-Thoracic Surgery 19:1, pages 47-53.
Crossref
Crossref
Takayuki Nakajima, Kohei Kawazoe, Kazuyuki Ishibashi, Yoshimitsu Kubota, Tatsuya Sasaki, Hiroshi Izumoto & Tohru Nitatori. (2000) Reduction of heparin dose is not beneficial to platelet function. The Annals of Thoracic Surgery 70:1, pages 186-190.
Crossref
Crossref
Patrícia Da Luz Moreira, Maria Lucia Furlan Wada & Waldyr P. Novello. (2001) Importance of Uniform Heparin Coating on Biopolymers. Artificial Organs 24:3, pages 209-211.
Crossref
Crossref
Christian Olsson, Agneta Siegbahn, Eric Haldén, Bo Nilsson, Per Venge & Stefan Thelin. (2000) No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. The Annals of Thoracic Surgery 69:3, pages 743-749.
Crossref
Crossref
Arthur E. Baue. 2000. Multiple Organ Failure. Multiple Organ Failure
82
85
.
Branko M. Weiss & Ludwig K. von Segesser. (1999) Pro and Con of heparin-bonded circuits for cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 13:5, pages 646-652.
Crossref
Crossref
H Wendel. (1999) Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. European Journal of Cardio-Thoracic Surgery 16:3, pages 342-350.
Crossref
Crossref
Hans Peter Wendel, Hans-Joachim Schulze, Wolfgang Heller & Hans-Martin Hoffmeister. (1999) Platelet protection in coronary artery surgery: Benefits of heparin-coated circuits and high-dose aprotinin therapy. Journal of Cardiothoracic and Vascular Anesthesia 13:4, pages 388-392.
Crossref
Crossref
George J. Despotis & J. Heinrich Joist. (1999) Anticoagulation and Anticoagulation Reversal With Cardiac Surgery Involving Cardiopulmonary Bypass: An Update. Journal of Cardiothoracic and Vascular Anesthesia 13:4, pages 18-29.
Crossref
Crossref
George J Despotis & Charles W HogueJr.Jr.. (1999) Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: a primer for cardiologists and an update for the cardiothoracic team. The American Journal of Cardiology 83:4, pages 15-30.
Crossref
Crossref
Hans P WendelAlbertus M Scheule, Friedrich S Eckstein & Gerhard Ziemer. (2016) Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. Perfusion 14:1, pages 21-28.
Crossref
Crossref
Rex L. Woolf & Monty G. Mythen. (1998) Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology. Journal of Cardiothoracic and Vascular Anesthesia 12:6, pages 710-712.
Crossref
Crossref
Linda Shore-Lesserson. (1998) Pro: heparin-bonded circuits represent a desirable option for cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 12:6, pages 705-709.
Crossref
Crossref
L.Henry EdmundsJrJr. (1998) Inflammatory response to cardiopulmonary bypass. The Annals of Thoracic Surgery 66:5, pages S12-S16.
Crossref
Crossref
J. S�nchez, G. Elgue, J. Riesenfeld & P. Olsson. (1997) Inhibition of the plasma contact activation system of immobilized heparin: Relation to surface density of functional antithrombin binding sites. Journal of Biomedical Materials Research 37:1, pages 37-42.
Crossref
Crossref
S Bannan. (1997) Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model. European Journal of Cardio-Thoracic Surgery 12:2, pages 268-275.
Crossref
Crossref
Sunao Watanabe, Kazuhide Hayashi, Hideki Yamanishi, Hideyuki Tomioka, Masaharu Minami, Noaki Shindoh & Kohji Miyamoto. (1997) Use of Percutaneous Cardiopulmonary Support System with Rotary Blood Pump in Graft Replacement of the Descending Thoracic and Thoracoabdominal Aorta. Artificial Organs 21:7, pages 846-851.
Crossref
Crossref
Kiyofumi Morishita, Satomi Inoue, Toshio Baba, Jyun‐ichi Sakata, Teruhisa Kazui & Tomio Abe. (2008) Our Distal Aortic Perfusion System in Descending Thoracic and Thoracoabdominal Aortic Aneurysm Repairs. Artificial Organs 21:7, pages 822-824.
Crossref
Crossref
Jan W. Borowiec, Mithat Bozdayi, Alfonso Jaramillo, Leif Nilsson, Per Venge & Axel Henze. (1997) Influence of Two Blood Conservation Techniques (Cardiotomy Reservoir Versus Cell-Saver) on Biocompatibility of the Heparin Coated Cardiopulmonary Bypass Circuit During Coronary Revascularization Surgery. Journal of Cardiac Surgery 12:3, pages 190-197.
Crossref
Crossref
Sally BannanMMedScMMedSc, Amanda DanbyHNDHND, Dahlia CowanBScBSc, Saeed AshrafFRCSFRCS & Paul G MartinPhDPhD. (1997) Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy?. The Annals of Thoracic Surgery 63:3, pages 663-668.
Crossref
Crossref
Anne H Kuitunen, MD, Lasse J Heikkilä, MD & Markku T Salmenperä, MD. (1997) Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation. The Annals of Thoracic Surgery 63:2, pages 438-444.
Crossref
Crossref
H E Høgevold, O Moen, E Fosse, P Venge, J Bråten, C Andersson & T Lyberg. (2016) Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Perfusion 12:1, pages 9-20.
Crossref
Crossref
Eivind Øvrum, Einfrid Åm Holen, Geir Tangen & Mari-Anne L. Ringdal. (1996) Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance. The Annals of Thoracic Surgery 62:4, pages 1128-1133.
Crossref
Crossref
LCH John & PB Deverall. (1996) CURRENT METHODS TO REDUCE THE ADVERSE HAEMATOLOGICAL CONSEQUENCES OF CARDIOPULMONARY BYPASS. International Journal of Clinical Practice 50:4, pages 203-206.
Crossref
Crossref
Robert C. Gorman, Nicholas P. Ziats, A.Koneti Rao, Nicolas Gikakis, Ling Sun, Mohammed M.H. Khan, Nina Stenach, Suneeti Sapatnekar, Vibhuti Chouhan, Joseph H. GormanIIIIII, Stefan Niewiarowski, Robert W. Colman, James M. Anderson & L.Henry EdmundsJr.Jr.. (1996) Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 111:1, pages 1-12.
Crossref
Crossref
John M. Gallagher, Michael E. Brown & Thomas A. Gasior. (1995) Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair. Journal of Cardiothoracic and Vascular Anesthesia 9:6, pages 728-730.
Crossref
Crossref
Eivind Øvrum, Tom Eirik Mollnes, Erik Fosse, Einfrid Åm Holen, Geir Tangen, Michel Abdelnoor, Mari-Anne L. Ringdal, Rolf Øystese & Per Venge. (1995) Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. The Journal of Thoracic and Cardiovascular Surgery 110:6, pages 1623-1632.
Crossref
Crossref
Eivind Øvrum, Tom Eirik Mollnes, Erik Fosse, Einfrid Åm Holen, Geir Tangen, Mari-Anne L. Ringdal & Vibeke Videm. (1995) High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes. The Annals of Thoracic Surgery 60:6, pages 1755-1761.
Crossref
Crossref
T. Lindhout, R. Blezer, P. Schoen, G. M. Willems, B. Fouache, M. Verhoeven, M. Hendriks, L. Cahalan & P. T. Cahalan. (2004) Antithrombin activity of surface‐bound heparin studied under flow conditions. Journal of Biomedical Materials Research 29:10, pages 1255-1266.
Crossref
Crossref
Eivind Øvrum, Einfrid Åm Holen, Geir Tangen, Frank Brosstad, Michel Abdelnoor, Mari-Anne L. Ringdal, Rolf Øystese & Reidar Istad. (1995) Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects. The Annals of Thoracic Surgery 60:2, pages 365-371.
Crossref
Crossref
J. Sanchez, G. Elgue, J. Riesenfeld & P. Olsson. (2004) Control of contact activation on end‐point immobilized heparin: The role of antithrombin and the specific antithrombin‐binding sequence. Journal of Biomedical Materials Research 29:5, pages 655-661.
Crossref
Crossref
Marcela Pekna, Leif Hagman, Eric Haldén, Ulf R. Nilsson, Bo Nilsson & Stefan Thelin. (1994) Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. The Annals of Thoracic Surgery 58:2, pages 421-424.
Crossref
Crossref
L.Henry EdmundsJrJr. (1994) Surface-bound heparin—Panacea or peril?. The Annals of Thoracic Surgery 58:2, pages 285-286.
Crossref
Crossref